Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The new version shows minor UI and formatting updates with no changes to the study's core details (eligibility, outcomes, dosing, or locations).
    Difference
    0.4%
    Check dated 2025-11-03T20:58:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T05:27:09.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:04:30.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-14T19:11:59.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.3%
    Check dated 2025-09-07T15:21:34.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while also removing several location-related terms and references to daratumumab and other medical resources.
    Difference
    2%
    Check dated 2025-08-31T11:51:31.000Z thumbnail image

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.